Evaluation of a new self-screening chart for cytomegalovirus retinitis in patients with AIDS

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue 4, 1996, Pages 336-342

  Teich, Steven A ^a,b,d   Saltzman, Brian R ^a,c  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Cytomegalovirus retinitis; Screening; Visual fields

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; MALE; OPHTHALMOSCOPY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RETINITIS; SCREENING TEST; SELF EXAMINATION; VISION TEST; VISUAL FIELD;

CYTOMEGALOVIRUS;

EID: 0029844966     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199612010-00006     Document Type: Article

References (30)

1. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1989;107: 75-80.
2. Karon JM, Rosenberg PS, McQuillan G, et al. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA 1996;276:126-31.
3. Teich SA, Cheung TW, Friedman AH. Systemic antiviral drugs used in ophthalmology. Surv Ophthalmol 1992;37:19-53.
4. Jones JL, Hanson DL, Ward JW, Kaplan JE. Incidence trends in AIDS-related opportunistic illnesses in injecting drug users and men who have sex with men [Poster]. XI International Conference on AIDS, Vancouver, B.C., Canada, 1996, abstr no. We.C.3418.
5. Dhillon B, MacLean H, Eddyshaw D, Cheong I, Flegg P, Brettle R. Cytomegalovirus retinitis and AIDS in Edinburgh. Int J STD AIDS 1993;4:339-41.
6. Dhillon B. The management of cytomegalovirus retinitis in AIDS. Br J Ophthalmol 1994;78:66-9.
7. Pertel P, Hirschtik R, Phair J, et al. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Def Synd 1992;5:1069-74.
8. Kupperman BD, Petty JG, Richman DD, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related non-infectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993;115:575-82.
9. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992;326:213-20.
10. Gallant JE, Moore RD, Richman DD, et al. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J infect Dis 1992;166:1223-7.
11. Holland GN, Buhles WC, Mastre B, et al. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. Arch Ophthalmol 1989;107:1759-66.
12. Palestine AG, Polis MA, DeSmet MD, et al. A randomized controlled study of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1991;115:665-73.
13. Bachman DM, Bruni LM, DiGioia RA, et al. Visual field testing in the management of cytomegalovirus retinitis. Ophthalmology 1992;99:1393-9.
14. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Foscarnet-ganciclovir cytomegalovirus trial: 4. Visual outcomes. Ophthalmology 1994;101:1250-61.
15. Holland GN, Sison RF, Jatulis DE, et al. Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. Ophthalmology 1990;97:204-11.
16. Polis MA, DeSmet MD, Baird BF, et al. Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet). Am J Med 1993;94:175-80.
17. Hartstein ME, Chin PK, Ku CW, Pak S. CMV retinitis screening in an urban population. Invest Ophthalmol Vis Sci 1994; 35(S):1893.
18. Morlett N, Young S, Dean R, Gold J. Ophthalmological screening for CMV retinitis in HIV infection. Lancet 1992;340:179.
19. Morlett N, Young S, Corneo MT. Risk factors for the development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol 1994;118:684-5.
20. Baldassano V, Dunn JP, Feinberg J, Jabs DA. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. N Engl J Med 1995; 333:670.
21. Gangan PA, Besen G, Munguia D, Freeman WR. Macular serous exudation in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. Am J Ophthalmol 1994;118:212-9.
22. Amsler M. Amsler charts manual. London: Hamblin (Instruments) Limited, 1949.
23. Fine AM, Elman MJ, Ebert JE, Prestia PA, Starr JS, Fine SL. Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol 1986;104:513-4.
24. Schucard RA. Validity and interpretation of Amsler grid reports. Arch Ophthalmol 1993;111:776-80.
25. Miller NR. Walsh and Hoyt's clinical neuro-ophthalmology, vol 1. 4th ed. Baltimore: Williams & Wilkins, 1982:111.
26. Fabricus E-M, Moller AA, Premtl F. Involvement of the afferent visual pathway in HIV infection. The optic nerve and optic radiation/visual cortex. Fortschr Ophthalmol 1991;88:721-30.
27. Slavin ML, Mallin JE, Jacob HS. Isolated homonymous hemianopsia in the acquired immunodeficiency syndrome. Am J Ophthalmol 1989;108:198-200.
28. Orefice G, Creti A, Bonadies G, Tullio-Cataldo P, Rubino S. Isolated homonymous lateral hemianopsia revealing central nervous system toxoplasmosis as the initial manifestation of AIDS. Metab Pediatr Syst Ophthalmol 1993;16:15-8.
29. Freeman WR, Friedberg DN, Berry C, et al. Risk factors for the development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol 1993;116:713-20.
30. Pinnolis M. Retinal detachment associated with cytomegalovirus retinitis. Semin Ophthalmol 1993;8:33-9.